Voloridge Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-45,736
| Closed | -$5.27M | – | 1304 |
|
|
2024
Q3 | $5.27M | Buy |
45,736
+29,918
| +189% | +$3.45M | 0.02% | 764 |
|
|
2024
Q2 | $2.18M | Sell |
15,818
-104,385
| -87% | -$14.4M | 0.01% | 930 |
|
|
2024
Q1 | $16.6M | Buy |
120,203
+98,194
| +446% | +$13.5M | 0.06% | 378 |
|
|
2023
Q4 | $2.9M | Buy |
+22,009
| New | +$2.9M | 0.01% | 742 |
|
|
2023
Q3 | – | Sell |
-11,347
| Closed | -$1.07M | – | 1532 |
|
|
2023
Q2 | $1.07M | Sell |
11,347
-98,409
| -90% | -$9.28M | 0.01% | 1109 |
|
|
2023
Q1 | $11.1M | Buy |
109,756
+74,129
| +208% | +$7.5M | 0.06% | 425 |
|
|
2022
Q4 | $4.26M | Buy |
+35,627
| New | +$4.26M | 0.02% | 701 |
|
|
2021
Q3 | – | Sell |
-32,103
| Closed | -$3.12M | – | 1786 |
|
|
2021
Q2 | $3.12M | Buy |
+32,103
| New | +$3.12M | 0.02% | 816 |
|
|
2021
Q1 | – | Sell |
-142,703
| Closed | -$13.7M | – | 1567 |
|
|
2020
Q4 | $13.7M | Buy |
142,703
+107,190
| +302% | +$10.3M | 0.11% | 213 |
|
|
2020
Q3 | $3.42M | Buy |
35,513
+27,414
| +338% | +$2.64M | 0.03% | 554 |
|
|
2020
Q2 | $988K | Sell |
8,099
-54,375
| -87% | -$6.63M | 0.01% | 853 |
|
|
2020
Q1 | $5.41M | Sell |
62,474
-60,797
| -49% | -$5.26M | 0.16% | 143 |
|
|
2019
Q4 | $13.3M | Buy |
+123,271
| New | +$13.3M | 0.26% | 87 |
|
|
2019
Q2 | – | Sell |
-22,971
| Closed | -$2.02M | – | 965 |
|
|
2019
Q1 | $2.02M | Sell |
22,971
-37,683
| -62% | -$3.32M | 0.06% | 291 |
|
|
2018
Q4 | $4.33M | Buy |
+60,654
| New | +$4.33M | 0.2% | 125 |
|
|
2018
Q3 | – | Sell |
-98,582
| Closed | -$9.69M | – | 410 |
|
|
2018
Q2 | $9.69M | Buy |
98,582
+50,903
| +107% | +$5M | 0.26% | 92 |
|
|
2018
Q1 | $3.95M | Sell |
47,679
-93,077
| -66% | -$7.72M | 0.09% | 190 |
|
|
2017
Q4 | $10.9M | Buy |
+140,756
| New | +$10.9M | 0.24% | 102 |
|
|
2015
Q3 | – | Sell |
-24,534
| Closed | -$1.17M | – | 365 |
|
|
2015
Q2 | $1.17M | Buy |
+24,534
| New | +$1.17M | 0.06% | 216 |
|